Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2018 Mar-2017 Mar-2016 Mar-2015
Growth matrix (%)        
Revenue growth (1) 18.40 (6.60) 1.21
Op profit growth (41) 4.08 99.90 (40)
EBIT growth (40) (15) 7,946 (105)
Net profit growth 10.70 (63) (590) (73)
Profitability ratios (%)        
OPM 6.70 11.20 12.70 5.95
EBIT margin 9.06 14.90 20.90 0.24
Net profit margin 4.44 3.97 12.80 (2.40)
RoCE 5.45 8.48 9.61 0.12
RoNW 0.73 0.67 1.90 (0.40)
RoA 0.67 0.56 1.47 (0.30)
Per share ratios ()        
EPS 1.33 1.20 3.25 --
Dividend per share -- -- -- --
Cash EPS (0.20) (0.10) 2.86 (3.50)
Book value per share 46.40 45 44.40 41.10
Valuation ratios        
P/E 29.20 33.70 11.80 --
P/CEPS (226) (323) 13.40 (3.10)
P/B 0.84 0.90 0.86 0.27
EV/EBIDTA 7.52 4.82 5.66 (3.30)
Payout (%)        
Dividend payout -- -- -- --
Tax payout (40) (40) (30) (84)
Liquidity ratios        
Debtor days 160 183 200 142
Inventory days 77.70 80.60 76.70 65.20
Creditor days (85) (105) (108) (67)
Leverage ratios        
Interest coverage (5.30) (5.50) (7.70) (0.10)
Net debt / equity (0.20) (0.30) (0.10) (0.50)
Net debt / op. profit (3.60) (3.70) (1.80) (13)
Cost breakup ()        
Material costs (58) (57) (52) (63)
Employee costs (16) (14) (13) (13)
Other costs (19) (18) (22) (18)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Revenue 62.80 63.50 53.60 57.40
yoy growth (%) (1) 18.40 (6.60) 1.21
Raw materials (36) (36) (28) (36)
As % of sales 57.70 57.20 52 62.90
Employee costs (10) (8.70) (7.20) (7.60)
As % of sales 16.30 13.70 13.40 13.30
Other costs (12) (11) (12) (10)
As % of sales 19.30 17.90 21.80 17.90
Operating profit 4.21 7.11 6.83 3.42
OPM 6.70 11.20 12.70 5.95
Depreciation (3.20) (2.80) (0.80) (6.10)
Interest expense (1.10) (1.70) (1.40) (1.70)
Other income 4.64 5.14 5.18 2.79
Profit before tax 4.62 7.75 9.74 (1.60)
Taxes (1.80) (3.10) (2.90) 1.31
Tax rate (40) (40) (30) (84)
Minorities and other -- -- -- --
Adj. profit 2.79 4.64 6.85 (0.20)
Exceptional items -- (2.10) -- (1.10)
Net profit 2.79 2.52 6.85 (1.40)
yoy growth (%) 10.70 (63) (590) (73)
NPM 4.44 3.97 12.80 (2.40)
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Profit before tax 4.62 7.75 9.74 (1.60)
Depreciation (3.20) (2.80) (0.80) (6.10)
Tax paid (1.80) (3.10) (2.90) 1.31
Working capital 22.80 (23) -- 22.70
Other operating items -- -- -- --
Operating cashflow 22.40 (21) 6.02 16.40
Capital expenditure (64) 16.30 -- (16)
Free cash flow (41) (4.60) 6.02 0.10
Equity raised 141 137 138 141
Investments 30.60 2.62 -- (2.60)
Debt financing/disposal (17) (18) -- 17.90
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 113 117 144 156
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2019 Mar-2018 Mar-2017 Mar-2016
Equity capital 21 21 21 21
Preference capital -- -- -- --
Reserves 77.20 76.50 73.70 72.40
Net worth 98.30 97.60 94.70 93.40
Minority interest
Debt 1.67 5.98 10.70 24.20
Deferred tax liabilities (net) -- -- -- --
Total liabilities 100 104 105 118
Fixed assets 7.90 10.20 15.40 14.70
Intangible assets
Investments 48.40 30.60 12.70 12.20
Deferred tax asset (net) 0.17 0.76 0.66 0.05
Net working capital 42.60 40.70 39.90 54.20
Inventories 14 13.70 13 15
Inventory Days -- 79.70 75 102
Sundry debtors 30 26 29.20 34.30
Debtor days -- 151 168 234
Other current assets 19.60 19 17.80 31.50
Sundry creditors (13) (13) (14) (19)
Creditor days -- 77.30 80.20 127
Other current liabilities (7.80) (4.70) (6.20) (8)
Cash 0.90 21.30 36.70 36.60
Total assets 99.90 104 105 118
Switch to
Consolidated
Standalone


Alpa Laboratories Ltd Report not showing data